Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/122308
Title: | Cost-effectiveness of nehanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients |
Author: | Soto, Marcelo Sampietro-Colom, Laura Lasalvia, Luis Mira, Aurea Jiménez Povedano, Wladimiro Navasa, Miquel |
Keywords: | Hepatitis C Malalties del fetge Hepatitis C Liver diseases |
Issue Date: | 7-May-2017 |
Publisher: | Baishideng Publishing Group |
Abstract: | AIM: To assess liver fibrosis (LF) in hepatitis C virus (HCV) and alcoholic liver disease (ALD), estimate health outcomes and costs of new noninvasive testing strategies. METHODS: A Markov model was developed to simulate LF progression in HCV and ALD for a cohort of 40-year-old men with abnormal levels of transaminases. Three different testing alternatives were studied: a single liver biopsy; annual Enhanced liver fibrosis (ELF ) followed by liver stiffness measurement (LSM) imaging as a confirmation test if the ELF test is positive; and annual ELF test without LSM. The analysis was performed from the perspective of a university hospital in Spain. Clinical data were obtained from published literature. Costs were sourced from administrative databases of the hospital. Deterministic and probabilistic sensitivity analyses were performed RESULTS: In HCV patients, annual sequential ELF test/LSM and annual ELF test alone prevented respectively 12.9 and 13.3 liver fibrosis-related deaths per 100 persons tested, compared to biopsy. The incremental cost-effectiveness ratios (ICERs) were respectively 13400 and 11500 per quality-adjusted life year (QALY). In ALD, fibrosis-related deaths decreased by 11.7 and 22.1 per 100 persons tested respectively with sequential ELF test/LSM and annual ELF test alone. ICERs were 280 and 190 per QALY, respectively. CONCLUSION: The use of the ELF test with or without a confirmation LSM are cost-effective options compared to a single liver biopsy for testing liver fibrosis in HCV and ALD patients in Spain. |
Note: | Reproducció del document publicat a: https://doi.org/10.3748/wjg.v23.i17.3163 |
It is part of: | World Journal of Gastroenterology, 2017, vol. 23, num. 17, p. 3163-3173 |
URI: | http://hdl.handle.net/2445/122308 |
Related resource: | https://doi.org/10.3748/wjg.v23.i17.3163 |
ISSN: | 1007-9327 |
Appears in Collections: | Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) Articles publicats en revistes (Biomedicina) Articles publicats en revistes (Medicina) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
672060.pdf | 2.59 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License